Treatment of female IBS patients with alosetron, a potent and selective 5HT3-receptor antagonist
Mangel, AW., Camilleri, M., Chey, WY., Hamm, LR., Harding, JP., Lawler, C., Dukes, GE., McSorley, D., Kong, S., Heath, AT., & Northcutt, AR. (1999). Treatment of female IBS patients with alosetron, a potent and selective 5HT3-receptor antagonist. Gastroenterology, 116(4), A1036-A1036.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Community overdose surveillance
Tailoring off the shelf global evidence with local implementation research can boost action on overweight and obesity